Christopher J Morabito
Directeur Technique/Scientifique/R&D chez ASTRIA THERAPEUTICS, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Christopher J Morabito
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 15/07/2022 | - |
Historique de carrière de Christopher J Morabito
Anciens postes connus de Christopher J Morabito
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 10/05/2021 | 13/07/2022 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Directeur Technique/Scientifique/R&D | 01/10/2016 | 01/07/2020 |
| MERCK & CO., INC. | Directeur/Membre du Conseil | 01/10/2010 | 01/04/2014 |
Cardurion Pharmaceuticals LLC
 Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Christopher J Morabito
| Franklin & Marshall College | Undergraduate Degree |
| Penn State Hershey College of Medicine | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Japon | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- Christopher J Morabito
- Expérience
